Showing results (351-360 of 385) with videos related to
Sort By:
Pageof 39
Cerebral Cortex (New York, N.Y. : 1991)|February 22, 2023
Using The Virtual Brain to study the relationship between structural and functional connectivity in patients with multiple sclerosis: a multicenter studyGerard Martí-Juan, Jaume Sastre-Garriga, Eloy Martinez-Heras, et al.Journal of the Neurological Sciences|May 15, 2025
Safety assessment of switching from fingolimod to siponimod: An Italian multicenter prospective studyGianmarco Abbadessa, Irene Schiavetti, Luca Bollo, et al.Therapeutic Advances in Neurological Disorders|June 9, 2021
Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategiesPietro Iaffaldano, Giuseppe Lucisano, Francesca Caputo, et al.Radiology|February 7, 2023
Multicenter Evaluation of AI-generated DIR and PSIR for Cortical and Juxtacortical Multiple Sclerosis Lesion DetectionPiet M Bouman, Samantha Noteboom, Fernando A Nobrega Santos, et al.Neurology|September 22, 2025
Toward a Unified Definition of Progression Independent of Relapse Activity in Multiple SclerosisEmilio Portaccio, Matteo Betti, Ermelinda De Meo, et al.JAMA Neurology|July 25, 2022
Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive Multiple SclerosisEmilio Portaccio, Mattia Fonderico, Pietro Iaffaldano, et al.Network Neuroscience (Cambridge, Mass.)|December 30, 2024
Conservation of structural brain connectivity in people with multiple sclerosisGerard Martí-Juan, Jaume Sastre-Garriga, Angela Vidal-Jordana, et al.Multiple Sclerosis Journal - Experimental, Translational and Clinical|March 28, 2019
Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndromeNaila Makhani, Christine Lebrun, Aksel Siva, et al.Journal of Clinical Medicine|April 23, 2022
Prognostic Markers of Ocrelizumab Effectiveness in Multiple Sclerosis: A Real World Observational Multicenter StudyRoberta Lanzillo, Antonio Carotenuto, Elisabetta Signoriello, et al.Journal of Neurology|August 23, 2024
Pediatric-onset Multiple Sclerosis treatment: a multicentre observational study comparing natalizumab with fingolimodAntonio Carotenuto, Cristina Di Monaco, Laura Papetti, et al.Pageof 39